Key indicators:

• Turnover up 14% compared with the same period in 2024
• EBITDA: 109 million lei, up 16% compared with the first nine months of 2024
• Stronger presence in the Consumer Healthcare (CHC) category and retention of the second position in volume on the market
• The company is the market leader by volume in the reference categories for six brands: Bixtonim, Colebil, Triferment, Extravalerianic, Carmol, and Carbocit

Bucharest, 17 Novvember 2025 – Biofarm, one of Romania’s leading manufacturers of medicines and dietary supplements, recorded solid financial growth in the first nine months of 2025, continuing the positive trend from the first half of the year.

The company’s turnover reached 263.2 million lei, 14% above the level in the comparable period of 2024, while EBITDA rose 16% to 109 million lei.

 „These results confirm our sustainable growth strategy, based on portfolio consolidation and ongoing investment in innovation and quality. In a complex market environment, we maintain a healthy pace of development, driven mainly by the performance of our established brands and operational discipline. We remain focused on expanding our Consumer Healthcare portfolio and responding quickly to consumer needs.” said Cătălin Vicol, CEO of Biofarm.

Biofarm strengthened its position in the Consumer Healthcare category, maintaining second place in volume at market level. Performance was supported by the stability of its main brands, with solid results in segments dedicated to pain management, digestive health, respiratory care and stress management. 
 
The company is the market leader by volume in the reference categories for six of its brands: Bixtonim, Colebil, Triferment, Extravalerianic, Carmol, and Carbocit. 
 
Biofarm operates two pharmaceutical factories in Bucharest and a product testing and development facility. Its portfolio of over 100 products covers the most important therapeutic areas in the Consumer Healthcare division (digestive & metabolic, respiratory & ORL, cardiovascular & circulatory, nervous system). Continuous innovation in product development remains one of the fundamental drivers of Biofarm’s expansion and the consolidation of its position among the leaders in the pharmaceutical industry.   

 

About Biofarm 

Biofarm® is one of the first Romanian drug and food supplements producers. For 100 years, Biofarm® has stood alongside Romanian specialists in the race to discover the best solutions for maintaining people's health. Biofarm® is currently one of the top 10 existing producers on the pharmaceutical market in Romania, a very dynamic and competitive market. Biofarm® has a competitive product portfolio, covering 65 therapeutic areas, and is continuously investing in media, commercial and marketing campaigns to promote its products.